1Letter from the Editor-in-ChiefKwok-fai So52Adult neurogenesis:a real hope or a delusion?Ghulam Hussain, Rabia Akram, Haseeb Anwar, Faiqa Sajid, Tehreem Iman, Hyung Soo Han, Chand Raza, Jose-Luis Gonzalez De Aguilar6-153Type-B monoamine oxidase inhibitors in neurological diseases:clinical applications based on preclinical findingsMarika Alborghetti, Edoardo Bianchini, Lanfranco De Carolis, Silvia Galli, Francesco E.Pontieri, Domiziana Rinaldi16-214The future of artificial hibernation medicine:protection of nerves and organs after spinal cord injuryCaiyun Liu, Haixin Yu, Zhengchao Li, Shulian Chen, Xiaoyin Li, Xuyi Chen, Bo Chen22-285Are TrkB receptor agonists the right tool to fulfill the promises for a therapeutic value of the brain-derived neurotrophic factor?Marta Zagrebelsky, Martin Korte29-346Pharmacological interventions targeting the microcirculation following traumatic spinal cord injuryRongrong Wang, Jinzhu Bai35-427Metabolic and proteostatic differences in quiescent and active neural stem cellsJiacheng Yu, Gang Chen, Hua Zhu, Yi Zhong, Zhenxing Yang, Zhihong Jian, Xiaoxing Xiong43-488Mesenchymal stem cell-derived extracellular vesicles as a cell-free therapy for traumatic brain injury via neuroprotection and neurorestorationYe Xiong, Asim Mahmood, Michael Chopp49-549Pathological and therapeutic effects of extracellular vesicles in neurological and neurodegenerative diseasesPaula Izquierdo-Altarejos, Victoria Moreno-Manzano, Vicente Felipo55-6110Emergence of taurine as a therapeutic agent for neurological disordersAshok Jangra, Priyanka Gola, Jiten Singh, Pooja Gond, Swarnabha Ghosh, Mahesh Rachamalla, Abhijit Dey, Danish Iqbal, Mehnaz Kamal, Punya Sachdeva, Saurabh Kumar Jha, Shreesh Ojha, Dinesh Kumar, Niraj Kumar Jha, Hitesh Chopra, Shing Cheng Tan62-6811Lactate metabolism in neurodegenerative diseasesChaoguang Yang, Rui-Yuan Pan, Fangxia Guan, Zengqiang Yuan69-7412Pathogenic and therapeutic role of exosomes in neurodegenerative disordersChrista C.Huber, Hongmin Wang75-7913Impact of apolipoprotein E isoforms on sporadic Alzheimer's disease:beyond the role of amyloid betaMadia Lozupone, Francesco Panza80-8314Understanding the spectrum of non-motor symptoms in multiple sclerosis:insights from animal modelsPoornima D.E.Weerasinghe-Mudiyanselage, Joong-Sun Kim, Taekyun Shin, Changjong Moon84-9115The concept of gene therapy for glaucoma:the dream that has not come true yetRobert Sulak, Xiaonan Liu, Adrian Smedowski92-9916Biomaterials-based anti-inflammatory treatment strategies for Alzheimer's diseaseJianjian Chu, Weicong Zhang, Yan Liu, Baofeng Gong, Wenbo Ji, Tong Yin, Chao Gao, Danqi Liangwen, Mengqi Hao, Cuimin Chen, Jianhua Zhuang, Jie Gao, You Yin100-11517Contribution of glial cells to the neuroprotective effects triggered by repetitive magnetic stimulation:a systematic reviewSusana A.Ferreira, Nuno Pinto, Inês Serrenho, Maria Vaz Pato, Graça Baltazar116-12318SIRT2 as a potential new therapeutic target for Alzheimer's diseaseNoemi Sola-Sevilla, Elena Puerta124-13119Strategies for translating proteomics discoveries into drug discovery for dementiaAditi Halder, Eleanor Drummond132-13920Clinical associations of corneal neuromas with ocular surface diseasesCharmaine Jan Li Toh, Chang Liu, Isabelle Xin Yu Lee, Molly Tzu Yu Lin, Louis Tong, Yu-Chi Liu140-147 